메뉴 건너뛰기




Volumn 61, Issue 7, 1997, Pages

Screening for novel drug effects with a microphysiometer: A potent effect of clofilium unrelated to potassium channel blockade

Author keywords

Antiarrhythmic agent; Cation channel blocker; Cellular metabolism; Clofilium; Cytosensor; Drug screen; Microphysiometer; Potassium channel blocker

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM TOSYLATE; CARBAMAZEPINE; CLOFILIUM; ION CHANNEL; LIDOCAINE; NIFEDIPINE; PHENYTOIN; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; PROPRANOLOL; TETRYLAMMONIUM; VERAPAMIL;

EID: 0343118753     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00543-2     Document Type: Article
Times cited : (12)

References (26)
  • 9
    • 0002769936 scopus 로고    scopus 로고
    • Design and optimization of dosage regimens; pharmacokinetic data
    • J. G. Hardman and L. E. Limbird (Eds.), McGraw-Hill, New York
    • L. Z. BENET, S. ÖIE, and J. B. SCHWARTZ, "Design and optimization of dosage regimens; pharmacokinetic data." In The Pharmacological Basis of Therapeutics, J. G. Hardman and L. E. Limbird (Eds.), 1707-1792, McGraw-Hill, New York (1996).
    • (1996) The Pharmacological Basis of Therapeutics , pp. 1707-1792
    • Benet, L.Z.1    Öie, S.2    Schwartz, J.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.